SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2012 / Cilt: 9 - Sayı: 1

Hs-CRP levels and cardiovascular risk parameters in Turkish obese women

Şişman Türk kadınlarında Hs-CRP düzeyleri ve kardiyovasküler risk göstergeleri

Sinan TANYOLAÇ
Ayşe ÇIKIM SERTKAYA
Pages
21–26
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients were divided in 3 categories according to their plasma hsCRP levels, and parameters were analyzed using one-way ANOVA. p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Obesity prevalence is rapidly increasing all over the world, composing a serious issue in public health.
📊
Key Findings & Data:Previous studies indicated a significant correlation between body fat mass and plasma hs-CRP levels.
💡
Conclusion & Impact:Patients were divided in 3 categories according to their plasma hsCRP levels, and parameters were analyzed using one-way ANOVA. p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Obesity prevalence is rapidly increasing all over the world, composing a serious issue in public health. Insulin resistance is encountered in many patients and chronic inflammation plays an important role in their pathophysiology. Previous studies indicated a significant correlation between body fat mass and plasma hs-CRP levels. In this study, we investigate the relationship between plasma hs-CRP levels and cardiovascular risk factors and metabolic syndrome parameters in Turkish obese female patients. Materials and methods: A total of 1007 overweight and obese women were examined retrospectively. Of these, 127 overweight (BMI = 25-30 kg/m2) and 880 obese (BMI  30 kg/m2) patients were evaluated in Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Obesity Outpatient Clinic. Anthropometric and biochemical parameters were measured. Patients were divided in 3 categories according to their plasma hsCRP levels, and parameters were analyzed using one-way ANOVA. p

Özet

Amaç: Şişmanlık prevalansı tüm dünyada hızla artış göstermekte ve önemli bir halk sağlığı sorunu oluşturmaktadır. Çoğu hastada insülin direnci görülmekte ve patofizyolojilerinde kronik inflamasyondan söz edilmektedir. Önceki çalışmalar, serum hs-CRP düzeyleri ile vücut yağ miktarı arasında anlamlı ilişkiler olduğunu göstermiştir. Bu çalışmamızda şişman Türk kadınlarında serum hs-CRP düzeyleri ile kardiyovasküler risk faktörleri ve metabolik sendrom parametreleri arasındaki ilişki araştırılmıştır. Gereç ve yöntem: Fazla kilolu ve şişman olan 1007 kadın retrospektif olarak incelendi. Bunlardan 127’si fazla kilolu (BMI = 25-30 kg/m2) ve 880’i ise şişman (BMI 30 kg/m2) hasta İstanbul Üniversitesi, İstanbul Tıp Fakültesi, İç Hastalıkları ABD, Şişmanlık Polikliniği’nde değerlendirildi. Antropometrik ve biyokimyasal parametreler ölçüldü. Serum hs-CRP düzeylerine göre hastalar üç gruba ayrılıp, parametreler tek yönlü ANOVA testi ile analiz edildi. p

🔖

Cite This Article

TANYOLAÇ, S., SERTKAYA, A. Ç. (2022). Hs-CRP levels and cardiovascular risk parameters in Turkish obese women. Endokrinolojide Diyalog Dergisi, Cilt: 9 - Sayı: 1, 21–26. https://ajindex.com/articles/500722

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428
  2. Festa A, D' Agostinho R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome. The insulin resistance atherosclerosis study (IRAS). Circulation 2002;102:42-47
  3. Haffner SM. The metabolic syndrome, inflammation, diabetes mellitus and cardiovascular disease. Am J Cardiol. 2006;97 (Suppl):3A-11A
  4. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399-409
  5. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:193–205
  6. Shoelson SE, Lee J, Goldfine AB Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–1801
  7. Ridker PM, Rifai N, Clearfield M, et al. Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;28:344(26):1959-65
  8. Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol. 2010;106:56-61
  9. Kutlutürk F, Bayraktaroğlu T, Azezli A, Orhan Y. Relation of high sensitive C-reactive protein and metabolic risk factors in overweight obese women. 10th European Congress on Endocrinology, 3-7 May 2007, Berlin, Germany. Endocrine Abstracts 2008, 16:P559
  10. Deurenberg P, Van der Kooji K, Evers P, Hulshof T. Assessment of body composition by electrical impedance in a population aged >60 years. Am J Clin Nutr. 1990;51:3-6
  11. Cox BD, Whichelow MJ. Ratio of waist circumference to height is better predictor of death than body mass index. Br Med J. 1996;313:1487-1491
  12. Bray GA. Classification and evaluation of the obesities. Med Clin North Am. 1989;73:161-184
  13. Gallagher D, Visser M, Sepulveda D, Pierson RN Jr, Harris T, Heymsfield SB. How useful body mass index for comparison of body fatness across age, gender and ethnic groups. Am J Epidemiol. 1996;143:228-239
  14. Asayama K, Hayashi K, Hayashibe H, Uchida N, Nakane T, Kodera K, Nakazawa S. Relationships between an index of body fat distribution (based on waist and hip circumferences) and stature and biochemical complications in obese children. Int J Obes. 1998;22:1209-1216
  15. Ashwell M, Cole TJ, Dixon AK. Obesity. New insight into the anthropometric classification of fat distribution shown by